TraceLink
TraceLink sells the OPUS no-code AI agent and digital network platform that automates supply chain operations for life sciences and healthcare companies.
TraceLink's OPUS Platform is a multienterprise SaaS network that lets life sciences and healthcare companies integrate once and build governed, no-code AI agents. These agents run supply chain processes alongside human teams. In 2026 the company says the network links more than 315,000 authenticated business entities and handles hundreds of billions of annual transactions. TraceLink was founded in 2009 and is privately held. Third-party databases estimate total funding at roughly $170M–$234M, and Series D was its last disclosed round (2018). It sells by subscription and has about 900+ employees.